The spinal device company saw a 47 percent sales growth year-over-year, which was attributed to Life Spine’s micro-invasive portfolio expansion.
According to Life Spine CFO Omar Faruqi, the company has “remained focused on launching products that are designed with the intention of reducing surgical procedure time, reducing operating costs and providing better patient outcomes.”
More articles on devices:
3 things to know about Viseon Spine
Medacta appoints general manager of U.S. spine division: 3 insights
Medtronic, DePuy Synthes & more: 11 device company launches, releases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
